D. Hackam's Profile

Role	Title	Level	Year	L/R
🐢	Shift work and vascular events: systematic review and meta-analysis 10 auth. M. Vyas, A. Garg, Arthur V. Iansavichus, J. Costella, A. Donner, L. E. Laugsand, ... I. Janszky, M. Mrkobrada, G. Parraga, D. Hackam	9	2012	9 🐢
🦁	Translation of research evidence from animals to humans. D. Hackam, D. Redelmeier	9	2006	9 🦁
🦁	Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence. D. Hackam, Sonia S Anand	9	2003	9 🦁
🐬	Carotid Plaque Area: A Tool for Targeting and Evaluating Vascular Preventive Therapy J. D. Spence, M. Eliasziw, M. Dicicco, D. Hackam, Ramzy Galil, Tara Lohmann	9	2002	9 🐬
🦁	The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy. 47 auth. D. Hackam, N. Khan, B. Hemmelgarn, S. Rabkin, R. Touyz, N. Campbell, R. Padwal, T. Campbell, M. Lindsay, M. Hill, R. Quinn, J. Mahon, R. Herman, E. Schiffrin, M. Ruzicka, ... P. Larochelle, R. Feldman, M. Lebel, L. Poirier, J. Arnold, G. Moe, J. Howlett, L. Trudeau, S. Bacon, R. Petrella, A. Milot, J. Stone, D. Drouin, J. Boulanger, Mukul Sharma, P. Hamet, G. Fodor, G. Dresser, S. Carruthers, G. Pylypchuk, E. Burgess, K. Burns, M. Vallée, G. Prasad, R. Gilbert, Lawrence A Leiter, Charlotte A Jones, R. Ogilvie, V. Woo, P. McFarlane, R. Hegele, S. Tobe	8	2010	8 🦁
🐬	Systematic review and meta-analysis: when one study is just not enough. A. Garg, D. Hackam, M. Tonelli	8	2008	8 🐬
🦁	Combining Multiple Approaches for the Secondary Prevention of Vascular Events After Stroke: A Quantitative Modeling Study D. Hackam, J. D. Spence	8	2007	8 🦁
🐜	Effects of intensive medical therapy on microemboli and cardiovascular risk in asymptomatic carotid stenosis. 12 auth. J. Spence, V. Coates, Hector Li, A. Tamayo, C. Muñoz, D. Hackam, ... M. Dicicco, J. Desroches, C. Bogiatzi, Jonathan Klein, J. Madrenas, R. Hegele	8	2010	8 🐜
🦁	Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis D. Hackam, M. Mamdani, Ping Li, D. Redelmeier	8	2006	8 🦁
🐢	Statins and sepsis: multiple modifications at multiple levels. M. Terblanche, Y. Almog, R. Rosenson, Terry S. Smith, D. Hackam	8	2007	8 🐢
🐢	Threats to Validity in the Design and Conduct of Preclinical Efficacy Studies: A Systematic Review of Guidelines for In Vivo Animal Experiments Valerie C. Henderson, J. Kimmelman, D. Fergusson, J. Grimshaw, D. Hackam	8	2013	8 🐢
🦁	Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study D. Hackam, D. Thiruchelvam, D. Redelmeier	8	2006	8 🦁